News & Events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

OncoArendi Therapeutics has closed its angel investment round raising

21 January 2014

OncoArendi has signed a contract agreement with the Polish Agency for Enterprise Development

5 November 2013

The Nencki Institute of Experimental Biology has just signed

6 June 2013

A patent application for the OAT-449

9 April 2013

Funding received for the first discovery program

7 September 2012

The contract was signed with the National Center for Research and Development

18 December 2009

Sign up for the latest News & Events

Events & Presentations

Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches – February 19-23, 2020 | Victoria, BC, Canada

27 February 2020

EFMC-ASMC’19 – September 1-5, 2019 | Athens, Greece

11 September 2019

ACS National Meeting & Expo – August 25 – 29, 2019 | San Diego, CA

4 September 2019

ATS- International Conference – Dallas, 17-22.05.2019

22 May 2019

EFMC – YMCS – Young Medicinal Chemist Symposium – Ljubljana 02-06.09.2018

17 September 2018

EFMC – International Symposium on Medicinal Chemistry – Ljubljana 02-06.09.2018

17 September 2018
This site is registered on wpml.org as a development site.